Date of Report (Date of earliest event reported)
|
July 26, 2019
|
Central Garden & Pet Company
|
(Exact name of registrant as specified in its charter)
|
Delaware
|
001-33268
|
68-0275553
|
(State or other jurisdiction
of incorporation) |
(Commission File
Number) |
(IRS Employer
Identification No.) |
1340 Treat Boulevard, Suite 600, Walnut Creek, California
|
94597
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant's telephone number, including area code
|
(925) 948-4000
|
(Former name or former address if changed since last report)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock
|
CENT
|
The NASDAQ Stock Market LLC
|
Class A Common Stock
|
CENTA
|
The NASDAQ Stock Market LLC
|
|
CENTRAL GARDEN & PET COMPANY
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Nicholas Lahanas
|
|
|
|
Nicholas Lahanas
|
|
|
|
Chief Financial Officer
|
|
|
|
(Principal Financial Officer)
|
|
Fiscal 3Q 2019 sales increased 7.4% to $706.6 million; Organic sales up 0.6%
Fiscal 3Q 2019 operating margin increased 50 basis points to 9.7%
Fiscal 3Q 2019 net income increased 11.1% to $46.2 million
Fiscal 3Q 2019 diluted EPS increased to $0.80 vs. $0.79 in Fiscal 3Q 2018
WALNUT CREEK, Calif.--(BUSINESS WIRE)--August 1, 2019--Central Garden & Pet Company (NASDAQ: CENT) (NASDAQ: CENTA), a leading innovator, producer and distributor of branded and private label products for the lawn & garden and pet supplies markets, today announced financial results for its fiscal 2019 third quarter ended June 29, 2019.
Fiscal 2019 Third Quarter Financial Results
Total net sales increased 7.4% to $706.6 million compared to $657.9 million in the third quarter a year ago, driven in large part by the acquisition of the remaining interest in Arden Companies, in February 2019, as well as organic growth in the Garden segment. Total Company organic sales increased 0.6%. Branded product sales of $565.6 million increased 9.4%, and sales of other manufacturers’ products of $141.0 million were relatively flat.
Third quarter operating income increased to $68.9 million from $60.8 million in the third quarter a year ago. Operating margin increased 50 basis points to 9.7% compared to 9.2%, due in part to a higher gross margin, which increased 30 basis points, as well as lower SG&A as a percent of sales. The gross margin improvement was aided by pricing and the benefits of the Company's systematic cost savings program. Corporate expenses for the period remained flat but included non-recurring costs of $1.7 million related to both the resolution of a legal matter and CEO search expenses incurred during the quarter. EBITDA for the quarter was $82.0 million versus $73.4 million in the third quarter a year ago.
Other income declined to $0.2 million compared to $2.1 million in the third quarter a year ago, primarily due to the absence of income from the Company's Arden business, which now is consolidated in the Garden segment.
Net income of $46.2 million increased 11.1% from $41.5 million in the third quarter a year ago. Earnings per diluted share increased to $0.80 in the quarter compared to $0.79 in the third quarter a year ago. The increase occurred despite a 5.4 million or 10.3% increase in the number of shares outstanding compared to a year ago, which reduced EPS by approximately eight cents.
"Led by strong results in two of our recent acquisitions and continued sequential quarterly improvement in year-over-year margin comparisons, Central resumed growing margins, operating income and EBITDA during the quarter," said George Roeth, President & CEO of Central Garden & Pet. "The growth occurred despite challenges in our Pet segment's animal health businesses, which faced significant headwinds caused in part by the difficult economic environment in the agricultural sector and extremely unfavorable weather for livestock and grain protection. We believe some of the quarterly shortfall in these businesses was related to timing and mix, and we continue to expect solid sales and profit growth in the fourth quarter compared to last year."
Roeth continued, "During the quarter, we took actions to strengthen our product portfolio. We acquired C&S Products, a manufacturer of suet and other wild bird feed products. C&S complements our existing wild bird feed business and fills a niche that previously we had to outsource for production. Also during the quarter, we exited two fashion-oriented pieces of our decor business. We made this decision due to the complexity and costs of operating the businesses, which while having made up over half of our decor revenues, were not profitable for Central. We remain committed to our terra cotta pottery business, which we will continue to operate going forward."
Garden Segment Fiscal 2019 Third Quarter Results
Third quarter net sales for the Garden segment rose 17.5% to $356.4 million, driven by the Arden acquisition and favorable organic growth, which increased 4.1% over the prior year period. Higher revenues from the Company's Bell Nursery business as well as a gain in the sales of other manufacturers' products drove the organic sales increase, which more than offset unfavorable weather conditions that resulted in lower sales of controls products. The Garden segment’s branded product sales were $294.6 million in the quarter, up 18.4% compared to the third quarter a year ago. Sales of other manufacturers’ products increased 13.8% to $61.8 million.
The Garden segment's operating income increased 29.7% to $53.1 million in the quarter from $40.9 million in the third quarter of fiscal 2018, and operating margin rose 140 basis points to 14.9%. Both operating income and margin increases were driven in large part by Arden and Bell Nursery, which helped overcome anticipated exit costs associated with the decor business. Garden EBITDA of $56.6 million was up from $43.7 million in the third quarter a year ago.
Pet Segment Fiscal 2019 Third Quarter Results
Third quarter net sales for the Pet segment decreased 1.3% to $350.2 million compared to the same period a year ago. Organic Pet sales were down 2.3%, due primarily to lower sales in the animal health and pet distribution businesses, which more than offset strength in the aquatics and dog treats businesses. The Pet segment’s third quarter branded product sales were $271.0 million, up 1.2% compared to a year ago, and sales of other manufacturers’ products were $79.2 million, a decrease of 8.8%.
The Pet segment’s operating income decreased 10.6% compared to the third quarter a year ago to $35.1 million, and Pet operating margin decreased to 10.0%, a decline of 110 basis points. Weakness in the animal health businesses, due to unfavorable weather, difficult economic conditions, and timing differences, negatively impacted third quarter operating income and margin. Changes in product sales mix and promotional expense timing in the Company's dog and cat businesses also negatively impacted Pet margins. Conversely, timing is expected to positively impact the Company's fourth quarter revenues and margins. Stronger orders already received early in the fourth quarter support this expectation. Pet EBITDA of $43.1 million was down from $46.9 million in the third quarter a year ago.
Year-to-date 2019 Summary:
Year-to-date net sales of $1,842.3 million increased 7.5% compared with $1,713.0 million a year ago, due in large part to acquisitions. Organic sales increased 0.6%, driven mainly by the Garden segment's 2.8% gain. Pet organic sales for the period declined 1.0%. Gross margin decreased 60 basis points to 30.2% from 30.8% in the first nine months of fiscal 2018 due to acquisitions. Organic gross margin during the period was relatively flat.
Operating income of $141.2 million decreased 5.3% or $7.9 million from $149.1 million in the first nine months of 2018, due in large part to lower Pet segment operating results, the impact of the inclusion of Bell Nursery for the full period compared to a year ago, and the delay of the implementation of pricing increases until the second fiscal quarter. Operating margin of 7.7% decreased 100 basis points from 8.7% in the first nine months of fiscal 2018.
Net income decreased 20.1% to $90.3 million from $113.0 million a year ago. Diluted earnings per share of $1.56 declined 27.4% from $2.15 per share, due in large part to the impact of a greater number of shares outstanding in the current year period and the positive impact from a revaluation of deferred tax amounts in the first quarter of fiscal 2018.
Additional Information
The Company's cash balance at the end of the quarter increased to $445.6 million compared to $204.4 million in the third quarter a year ago, reflecting the proceeds of the Company's equity offering in August 2018. Cash provided by operations during the quarter increased $60.4 million to $172.1 million compared to $111.7 million a year ago due to higher earnings and stronger working capital management. Total debt at June 29, 2019 was $693.1 million compared to $691.9 million at June 30, 2018. Net interest expense of $8.5 million for the third quarter decreased $1.5 million from $10.0 million in the prior-year period, mainly due to interest earned on the Company's higher cash balances during the quarter. The Company's leverage ratio at the end of the third quarter, as defined in the Company's credit agreement, was 3.0x compared to 3.2x at the end of the prior year quarter.
The Company’s effective tax rate for the third quarter of 2019 was 23.5%, compared with 21.5% for the third quarter of 2018.
2019 Guidance
The Company is changing its previous fiscal 2019 guidance of $1.80 or higher per diluted share. The Company now expects earnings per diluted share of $1.72 or higher for the current fiscal year. The reduction is driven by short-term challenges in the Company's animal health businesses, and three cents of negative impact from an unexpected legal resolution and cumulative CEO transition costs, which were not included in the Company's previous guidance.
Conference Call
The Company will host a conference call today at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time to discuss its third quarter results. The conference call will be accessible via the internet through Central’s website, http://ir.central.com.
Alternatively, to listen to the call by telephone, dial (201) 689-8345 (domestic and international) using confirmation #13691792. A replay of the call will be available for three days by dialing (201) 612-7415 and entering confirmation #13691792.
About Central Garden & Pet
Central Garden & Pet Company is a leading innovator, producer and distributor of branded and private label products for the lawn & garden and pet supplies markets. Committed to new product innovation, our products are sold to specialty independent and mass retailers. Participating categories in Lawn & Garden include: Grass seed and the brands PENNINGTON®, and THE REBELS®; wild bird feed and the brand PENNINGTON®; weed and insect control and the brands AMDRO®, SEVIN®, and OVER-N-OUT®; fertilizer and the brands PENNINGTON® and IRONITE®; live plants from BELL NURSERY; outdoor cushions and pillows from ARDEN COMPANIES; and decorative outdoor patio products under the PENNINGTON® brand. We also provide a host of other regional and application-specific garden brands and supplies. Participating categories in Pet include: Animal health and the brands ADAMS™, COMFORT ZONE®, FARNAM®, HORSE HEALTH™ and VITAFLEX®; aquatics and reptile and the brands AQUEON®, CORALIFE®, SEGREST™ and ZILLA®; bird & small animal and the brands KAYTEE®, Forti-Diet® and CRITTER TRAIL®; and dog & cat and the brands TFH™, NYLABONE®, FOUR PAWS®, IMS®, CADET®, DMC™, K&H Pet Products™, PINNACLE® and AVODERM®. We also provide a host of other application-specific pet brands and supplies. Central Garden & Pet Company is based in Walnut Creek, California, and has approximately 5,400 employees, primarily in North America. For additional information on Central Garden & Pet Company, including access to the Company's SEC filings, please visit the Company’s website at www.central.com.
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this release which are not historical facts, including expectations for future financial results, earnings guidance for fiscal 2019 expected cost and mix improvements in the second half of fiscal 2019 and new product offerings, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward-looking statements. All forward-looking statements are based upon the Company’s current expectations and various assumptions. There are a number of risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements contained in this release including, but not limited to, the following factors:
These risks and others are described in the Company’s Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update these forward-looking statements to reflect new information, subsequent events or otherwise.
CENTRAL GARDEN & PET COMPANY |
|||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||||||||
(in thousands, except share and per share amounts) |
|||||||||||
(Unaudited) |
|||||||||||
ASSETS |
June 29, 2019 |
|
June 30, 2018 |
|
September 29, 2018 |
||||||
Current assets: |
|
|
|
|
|
||||||
Cash and cash equivalents |
$ |
445,632 |
|
|
$ |
204,388 |
|
|
$ |
482,106 |
|
Restricted cash |
10,924 |
|
|
13,978 |
|
|
10,899 |
|
|||
Short term investments |
119 |
|
|
— |
|
|
— |
|
|||
Accounts receivable (less allowance for doubtful accounts of $15,875, $22,021 and $24,125) |
395,581 |
|
|
348,781 |
|
|
275,908 |
|
|||
Inventories, net |
464,917 |
|
|
428,007 |
|
|
427,823 |
|
|||
Prepaid expenses and other |
32,453 |
|
|
26,735 |
|
|
20,562 |
|
|||
Total current assets |
1,349,626 |
|
|
1,021,889 |
|
|
1,217,298 |
|
|||
|
|
|
|
|
|
||||||
Land, buildings, improvements and equipment—net |
238,948 |
|
|
211,817 |
|
|
217,647 |
|
|||
Goodwill |
281,177 |
|
|
268,243 |
|
|
281,177 |
|
|||
Other intangible assets—net |
139,406 |
|
|
138,610 |
|
|
152,265 |
|
|||
Other assets |
55,761 |
|
|
67,846 |
|
|
38,822 |
|
|||
Total |
$ |
2,064,918 |
|
|
$ |
1,708,405 |
|
|
$ |
1,907,209 |
|
|
|
|
|
|
|
||||||
LIABILITIES AND EQUITY |
|
|
|
|
|
||||||
Current liabilities: |
|
|
|
|
|
||||||
Accounts payable |
$ |
137,668 |
|
|
$ |
108,129 |
|
|
$ |
110,259 |
|
Accrued expenses |
141,029 |
|
|
122,897 |
|
|
102,583 |
|
|||
Current portion of long-term debt |
116 |
|
|
119 |
|
|
122 |
|
|||
Total current liabilities |
278,813 |
|
|
231,145 |
|
|
212,964 |
|
|||
|
|
|
|
|
|
||||||
Long-term debt |
692,948 |
|
|
691,741 |
|
|
692,031 |
|
|||
Deferred taxes and other long-term obligations |
58,834 |
|
|
40,798 |
|
|
49,380 |
|
|||
|
|
|
|
|
|
||||||
Equity: |
|
|
|
|
|
||||||
Common stock, $0.01 par value: 12,145,135 shares outstanding at June 29, 2019, June 30, 2018 and September 29, 2018 |
121 |
|
|
121 |
|
|
121 |
|
|||
Class A common stock, $0.01 par value: 44,081,467, 38,373,324 and 43,953,265 shares outstanding at June 29, 2019, June 30, 2018 and September 29, 2018 |
440 |
|
|
384 |
|
|
439 |
|
|||
Class B stock, $0.01 par value: 1,652,262 shares outstanding |
16 |
|
|
16 |
|
|
16 |
|
|||
Additional paid-in capital |
589,849 |
|
|
392,412 |
|
|
590,168 |
|
|||
Accumulated earnings |
444,645 |
|
|
352,355 |
|
|
362,923 |
|
|||
Accumulated other comprehensive loss |
(1,426 |
) |
|
(1,153 |
) |
|
(1,218 |
) |
|||
Total Central Garden & Pet Company shareholders’ equity |
1,033,645 |
|
|
744,135 |
|
|
952,449 |
|
|||
Noncontrolling interest |
678 |
|
|
586 |
|
|
385 |
|
|||
Total equity |
1,034,323 |
|
|
744,721 |
|
|
952,834 |
|
|||
Total |
$ |
2,064,918 |
|
|
$ |
1,708,405 |
|
|
$ |
1,907,209 |
|
CENTRAL GARDEN & PET COMPANY |
|||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
|||||||||||||||
(in thousands, except per share amounts) |
|||||||||||||||
(Unaudited) |
|||||||||||||||
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
June 29, 2019 |
|
June 30, 2018 |
|
June 29, 2019 |
|
June 30, 2018 |
||||||||
Net sales |
$ |
706,575 |
|
|
$ |
657,943 |
|
|
$ |
1,842,266 |
|
|
$ |
1,713,048 |
|
Cost of goods sold and occupancy |
487,291 |
|
|
455,879 |
|
|
1,286,749 |
|
|
1,184,690 |
|
||||
Gross profit |
219,284 |
|
|
202,064 |
|
|
555,517 |
|
|
528,358 |
|
||||
Selling, general and administrative expenses |
150,413 |
|
|
141,245 |
|
|
414,312 |
|
|
379,232 |
|
||||
Operating income |
68,871 |
|
|
60,819 |
|
|
141,205 |
|
|
149,126 |
|
||||
Interest expense |
(10,676 |
) |
|
(10,597 |
) |
|
(31,930 |
) |
|
(28,577 |
) |
||||
Interest income |
2,178 |
|
|
584 |
|
|
6,970 |
|
|
1,464 |
|
||||
Other income |
180 |
|
|
2,126 |
|
|
488 |
|
|
542 |
|
||||
Income before income taxes and noncontrolling interest |
60,553 |
|
|
52,932 |
|
|
116,733 |
|
|
122,555 |
|
||||
Income tax expense |
14,212 |
|
|
11,395 |
|
|
26,031 |
|
|
8,802 |
|
||||
Income including noncontrolling interest |
46,341 |
|
|
41,537 |
|
|
90,702 |
|
|
113,753 |
|
||||
Net income (loss) attributable to noncontrolling interest |
189 |
|
|
(8 |
) |
|
356 |
|
|
727 |
|
||||
Net income attributable to Central Garden & Pet Company |
$ |
46,152 |
|
|
$ |
41,545 |
|
|
$ |
90,346 |
|
|
$ |
113,026 |
|
|
|
|
|
|
|
|
|
||||||||
Net income per share attributable to Central Garden & Pet Company: |
|
|
|
|
|
|
|
||||||||
Basic |
$ |
0.81 |
|
|
$ |
0.81 |
|
|
$ |
1.58 |
|
|
$ |
2.22 |
|
Diluted |
$ |
0.80 |
|
|
$ |
0.79 |
|
|
$ |
1.56 |
|
|
$ |
2.15 |
|
|
|
|
|
|
|
|
|
||||||||
Weighted average shares used in the computation of net income per share: |
|
|
|
|
|
|
|
||||||||
Basic |
57,319 |
|
|
51,134 |
|
|
57,021 |
|
|
50,938 |
|
||||
Diluted |
57,985 |
|
|
52,575 |
|
|
57,937 |
|
|
52,670 |
|
Use of Non-GAAP Financial Measures
We report our financial results in accordance with U.S. generally accepted accounting principles (GAAP). However, to supplement the financial results prepared in accordance with GAAP, we use non-GAAP financial measures including non-GAAP net sales and operating income on a consolidated and segment basis, and non-GAAP net income and diluted net income per share. Management believes these non-GAAP financial measures that exclude the impact of specific items (described below) may be useful to investors in their assessment of our ongoing operating performance and provide additional meaningful comparisons between current results and results in prior operating periods.
EBITDA is defined by us as income before income tax, net other expense, net interest expense and depreciation and amortization (or operating income plus depreciation and amortization expense). We present EBITDA because we believe that EBITDA is a useful supplemental measure in evaluating the cash flows and performance of our business and provides greater transparency into our results of operations. EBITDA is used by our management to perform such evaluation. EBITDA should not be considered in isolation or as substitutes for cash flow from operations, income from operations or other income statement measures prepared in accordance with GAAP. We believe that EBITDA is frequently used by investors, securities analysts and other interested parties in their evaluation of companies, many of which present EBITDA when reporting their results. Other companies may calculate EBITDA differently, it may not be comparable.
We have also provided organic net sales, a non-GAAP measure that excludes the impact of businesses purchased or exited in the prior 12 months, because we believe it permits investors to better understand the performance of our historical business without the impact of recent acquisitions or dispositions.
The reconciliations of these non-GAAP measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are shown in the tables below. We have not provided a reconciliation of non-GAAP guidance measures to the corresponding GAAP measures on a forward-looking basis due to the potential significant variability and limited visibility of the excluded items. We believe that the non-GAAP financial measures provide useful information to investors and other users of our financial statements by allowing for greater transparency in the review of our financial and operating performance. Management also uses these non-GAAP financial measures in making financial, operating and planning decisions and in evaluating our performance, and we believe these measures similarly may be useful to investors in evaluating our financial and operating performance and the trends in our business from management's point of view. While our management believes that non-GAAP measurements are useful supplemental information, such adjusted results are not intended to replace our GAAP financial results and should be read in conjunction with those GAAP results.
Non-GAAP financial measures reflect adjustments based on the following items:
From time to time in the future, there may be other items that we may exclude if we believe that doing so is consistent with the goal of providing useful information to investors and management.
(1) |
During the second quarter of fiscal 2019, we recorded a preliminary, pending the finalization of the related purchase accounting, non-cash $3.2 million gain in our Garden segment from the fair value remeasurement of our previously held 45% interest in Arden upon our acquisition of the remaining 55% interest. The gain was recorded as part of selling, general and administrative costs in the condensed consolidated statements of operations. |
(2) |
During the second quarter of fiscal 2019, we recognized a non-cash impairment charge in our Pet segment of $2.5 million related to the impairment of intangible assets caused by a retail customer exiting the live fish business. The adjustment was recorded as part of selling, general and administrative costs. |
(3) |
Transitional impact of U.S. Tax Reform: As a result of the Tax Reform Act, the Company recorded a provisional tax benefit of $16.3 million in the first quarter of fiscal 2018, due to the remeasurement of its deferred tax assets and liabilities. We have excluded only this transitional impact and have not included in the adjustment the ongoing impact of the lower U.S. statutory rate on our current or future year earnings. |
Operating Income Reconciliation |
|
GAAP to Non-GAAP Reconciliation |
||||||
|
|
Consolidated |
||||||
|
|
June 29, 2019 |
|
June 30, 2018 |
||||
GAAP operating income |
|
$ |
141,205 |
|
|
$ |
149,126 |
|
Previously held investment interest fair value remeasurement |
(1) |
(3,215 |
) |
|
— |
|
||
Intangible asset impairment |
(2) |
2,540 |
|
|
— |
|
||
Non-GAAP operating income |
|
$ |
140,530 |
|
|
$ |
149,126 |
|
Pet Segment Operating Income Reconciliation |
|
GAAP to Non-GAAP Reconciliation |
||||||
|
|
Pet |
||||||
|
|
June 29, 2019 |
|
June 30, 2018 |
||||
GAAP operating income |
|
$ |
91,805 |
|
|
$ |
108,202 |
|
Intangible asset impairment |
(2) |
2,540 |
|
|
— |
|
||
Non-GAAP operating income |
|
$ |
94,345 |
|
|
$ |
108,202 |
|
Garden Segment Operating Income Reconciliation |
|
GAAP to Non-GAAP Reconciliation |
||||||
|
|
Garden |
||||||
|
|
June 29, 2019 |
|
June 30, 2018 |
||||
GAAP operating income |
|
$ |
101,821 |
|
|
$ |
93,975 |
|
Previously held investment interest fair value remeasurement |
(1) |
(3,215 |
) |
|
— |
|
||
Non-GAAP operating income |
|
$ |
98,606 |
|
|
$ |
93,975 |
|
|
GAAP to Non-GAAP Reconciliation |
|||||||
Net Income and Diluted Net Income Per Share Reconciliation |
|
June 29, 2019 |
|
June 30, 2018 |
||||
GAAP net income attributable to Central Garden & Pet |
|
$ |
90,346 |
|
|
$ |
113,026 |
|
Previously held investment interest fair value remeasurement |
(1) |
(3,215 |
) |
|
— |
|
||
Intangible asset impairment |
(2) |
2,540 |
|
|
— |
|
||
Tax effect of remeasurement and impairment |
|
151 |
|
|
— |
|
||
Tax effect of revaluation of deferred tax amounts |
(3) |
— |
|
|
16,343 |
|
||
Non-GAAP net income attributable to Central Garden & Pet |
|
$ |
89,822 |
|
|
$ |
96,683 |
|
GAAP diluted net income per share |
|
$ |
1.56 |
|
|
$ |
2.15 |
|
Non-GAAP diluted net income per share |
|
$ |
1.55 |
|
|
$ |
1.84 |
|
Shares used in GAAP and non-GAAP diluted net earnings per share calculation |
|
57,937 |
|
|
52,670 |
|
Organic Net Sales Reconciliation
We have provided organic net sales, a non-GAAP measure that excludes the impact of recent acquisitions and dispositions, because we believe it permits investors to better understand the performance of our historical business. We define organic net sales as net sales from our historical business derived by excluding the net sales from businesses acquired or exited in the preceding 12 months. After an acquired business has been part of our consolidated results for 12 months, the change in net sales thereafter is considered part of the increase or decrease in organic net sales.
|
|
GAAP to Non-GAAP Reconciliation |
|||||||||||||||||||
|
|
Consolidated |
|
Pet Segment |
|
Garden Segment |
|||||||||||||||
|
|
|
|
Percent |
|
|
|
Percent |
|
|
|
Percent |
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Reported net sales - Q3 FY19 (GAAP) |
|
$ |
706.6 |
|
|
|
|
$ |
350.2 |
|
|
|
|
$ |
356.4 |
|
|
|
|||
Reported net sales - Q3 FY18 (GAAP) |
|
657.9 |
|
|
|
|
354.7 |
|
|
|
|
303.2 |
|
|
|
||||||
Increase in net sales |
|
48.7 |
|
|
7.4 |
% |
|
(4.5 |
) |
|
(1.3 |
)% |
|
53.2 |
|
|
17.5 |
% |
|||
Effect of acquisition and divestitures on increase in net sales |
|
44.6 |
|
|
|
|
3.7 |
|
|
|
|
40.9 |
|
|
|
||||||
Increase in organic net sales - Q3 2019 |
|
$ |
4.1 |
|
|
0.6 |
% |
|
$ |
(8.2 |
) |
|
(2.3 |
)% |
|
$ |
12.3 |
|
|
4.1 |
% |
|
|
GAAP to Non-GAAP Reconciliation |
|||||||||||||||||||
|
|
Consolidated |
|
Pet Segment |
|
Garden Segment |
|||||||||||||||
|
|
|
|
Percent |
|
|
|
Percent |
|
|
|
Percent |
|||||||||
Reported net sales - Q3 FY19 YTD (GAAP) |
|
$ |
1,842.3 |
|
|
|
|
$ |
1,028.8 |
|
|
|
|
$ |
813.5 |
|
|
|
|||
Reported net sales - Q3 FY18 YTD (GAAP) |
|
1,713.0 |
|
|
|
|
1,001.5 |
|
|
|
|
711.5 |
|
|
|
||||||
Increase in net sales |
|
129.3 |
|
|
7.5 |
% |
|
27.3 |
|
|
2.7 |
% |
|
102.0 |
|
|
14.3 |
% |
|||
Effect of acquisition and divestitures on increase in net sales |
|
119.5 |
|
|
|
|
37.2 |
|
|
|
|
82.3 |
|
|
|
||||||
Increase (decrease) in organic net sales - Q3 2019 YTD |
|
$ |
9.8 |
|
|
0.6 |
% |
|
$ |
(9.9 |
) |
|
(1.0 |
)% |
|
$ |
19.7 |
|
|
2.8 |
% |
EBITDA Reconciliation |
|
GAAP to Non-GAAP Reconciliation |
||||||||||||||
|
|
Garden |
|
Pet |
|
Corp |
|
Total |
||||||||
Net income attributable to Central Garden & Pet |
|
— |
|
|
— |
|
|
— |
|
|
$ |
46,152 |
|
|||
Interest expense, net |
|
— |
|
|
— |
|
|
— |
|
|
8,498 |
|
||||
Other income |
|
— |
|
|
— |
|
|
— |
|
|
(180 |
) |
||||
Income tax expense |
|
— |
|
|
— |
|
|
— |
|
|
14,212 |
|
||||
Net income attributable to noncontrolling interest |
|
— |
|
|
— |
|
|
— |
|
|
189 |
|
||||
Sum of items below operating income |
|
— |
|
|
— |
|
|
— |
|
|
22,719 |
|
||||
Income (loss) from operations |
|
$ |
53,103 |
|
|
$ |
35,066 |
|
|
$ |
(19,298 |
) |
|
$ |
68,871 |
|
Depreciation & amortization |
|
3,497 |
|
|
8,083 |
|
|
1,502 |
|
|
13,082 |
|
||||
EBITDA |
|
$ |
56,600 |
|
|
$ |
43,149 |
|
|
$ |
(17,796 |
) |
|
$ |
81,953 |
|
EBITDA Reconciliation |
|
GAAP to Non-GAAP Reconciliation |
||||||||||||||
|
|
Garden |
|
Pet |
|
Corp |
|
Total |
||||||||
Net income attributable to Central Garden & Pet |
|
— |
|
— |
|
— |
|
$ |
41,545 |
|
||||||
Interest expense, net |
|
— |
|
— |
|
— |
|
10,013 |
|
|||||||
Other income |
|
— |
|
— |
|
— |
|
(2,126 |
) |
|||||||
Income tax expense |
|
— |
|
— |
|
— |
|
11,395 |
|
|||||||
Net income attributable to noncontrolling interest |
|
— |
|
— |
|
— |
|
(8 |
) |
|||||||
Sum of items below operating income |
|
— |
|
— |
|
— |
|
19,274 |
|
|||||||
Income (loss) from operations |
|
$ |
40,929 |
|
|
$ |
39,242 |
|
|
$ |
(19,352 |
) |
|
$ |
60,819 |
|
Depreciation & amortization |
|
2,789 |
|
|
7,626 |
|
|
2,172 |
|
|
12,587 |
|
||||
EBITDA |
|
$ |
43,718 |
|
|
$ |
46,868 |
|
|
$ |
(17,180 |
) |
|
$ |
73,406 |
|
EBITDA Reconciliation |
|
GAAP to Non-GAAP Reconciliation |
||||||||||||||
|
|
Garden |
|
Pet |
|
Corp |
|
Total |
||||||||
Net income attributable to Central Garden & Pet |
|
— |
|
|
— |
|
|
— |
|
|
$ |
90,346 |
|
|||
Interest expense, net |
|
— |
|
|
— |
|
|
— |
|
|
24,960 |
|
||||
Other income |
|
— |
|
|
— |
|
|
— |
|
|
(488 |
) |
||||
Income tax benefit |
|
— |
|
|
— |
|
|
— |
|
|
26,031 |
|
||||
Net income attributable to noncontrolling interest |
|
— |
|
|
— |
|
|
— |
|
|
356 |
|
||||
Sum of items below operating income |
|
— |
|
|
— |
|
|
— |
|
|
50,859 |
|
||||
Income (loss) from operations |
|
$ |
101,821 |
|
|
$ |
91,805 |
|
|
$ |
(52,421 |
) |
|
$ |
141,205 |
|
Depreciation & amortization |
|
8,635 |
|
|
24,178 |
|
|
4,498 |
|
|
37,311 |
|
||||
EBITDA |
|
$ |
110,456 |
|
|
$ |
115,983 |
|
|
$ |
(47,923 |
) |
|
$ |
178,516 |
|
EBITDA Reconciliation |
|
GAAP to Non-GAAP Reconciliation |
||||||||||||||
|
|
Garden |
|
Pet |
|
Corp |
|
Total |
||||||||
Net income attributable to Central Garden & Pet |
|
— |
|
|
— |
|
|
— |
|
|
$ |
113,026 |
|
|||
Interest expense, net |
|
— |
|
|
— |
|
|
— |
|
|
27,113 |
|
||||
Other income (expense) |
|
— |
|
|
— |
|
|
— |
|
|
(542 |
) |
||||
Income tax benefit |
|
— |
|
|
— |
|
|
— |
|
|
8,802 |
|
||||
Net income attributable to noncontrolling interest |
|
— |
|
|
— |
|
|
— |
|
|
727 |
|
||||
Sum of items below operating income |
|
— |
|
|
— |
|
|
— |
|
|
36,100 |
|
||||
Income (loss) from operations |
|
$ |
93,975 |
|
|
$ |
108,202 |
|
|
$ |
(53,051 |
) |
|
$ |
149,126 |
|
Depreciation & amortization |
|
6,065 |
|
|
21,715 |
|
|
7,092 |
|
|
34,872 |
|
||||
EBITDA |
|
$ |
100,040 |
|
|
$ |
129,917 |
|
|
$ |
(45,959 |
) |
|
$ |
183,998 |
|
Steve Zenker
VP Finance - Investor Relations, FP&A, & Corporate Communications
Central Garden & Pet Company
925.948.3657